Keyphrases
Acute Myocardial Infarction
5%
AIDS/HIV
31%
Air Sampling
6%
Airborne Transmission
5%
Antiretroviral
7%
Antiretroviral Therapy
25%
Broth Culture
5%
Cardiovascular Disease
6%
Caterpillar
6%
Clinical Manifestations
7%
Consulting Room
5%
Cough
12%
Cough Frequency
13%
Cryptosporidium
6%
Cryptosporidium Infection
6%
Drug Resistance
10%
Drug Susceptibility Testing
21%
Emergency Department
7%
Erucism
8%
First-line Antiretroviral Therapy
9%
Guinea pig
7%
Health Personnel
8%
Healthcare Workers
5%
HIV Drug Resistance
8%
HIV Infection
9%
HIV Patients
19%
HIV-negative Patients
5%
HIV-positive
8%
HIV-positive Adults
5%
Human Immunodeficiency Virus Infection
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
6%
Immunocompromised Patients
6%
Infection Control
9%
Infection Control Measures
9%
Infectiousness
11%
Influenza Vaccine Effectiveness
8%
Influenza Virus
5%
Latent Tuberculosis Infection
14%
Lima
47%
Lonomia
8%
Low-resource Settings
5%
Lymphadenopathy
5%
Microscopic Observation Drug Susceptibility
15%
Multidrug-resistant Mycobacterium Tuberculosis
8%
Multidrug-resistant Tuberculosis (MDR-TB)
30%
Mycobacterium Tuberculosis (M. tb)
13%
National Hospital
5%
Natural Ventilation
8%
Nosocomial Tuberculosis
5%
Peru
100%
Peruvian
18%
Public Health Risk
5%
Pulmonary Tuberculosis
29%
Quantitative PCR
7%
Resource-poor Settings
5%
Sampling Model
5%
Sputum
6%
Toxoplasma Gondii (T. gondii)
6%
Transmission Risk
8%
Tuberculosis
49%
Tuberculosis Diagnosis
7%
Tuberculosis Disease
8%
Tuberculosis Infection
5%
Tuberculosis Infection Control
5%
Tuberculosis Mortality
5%
Tuberculosis Patients
7%
Tuberculosis Transmission
21%
Tuberculosis Treatment
10%
Tuberculous Meningitis
8%
Virological Failure
6%
Waiting Room
5%
Medicine and Dentistry
Acute Heart Infarction
5%
Airborne Infection
6%
Antiretroviral Therapy
17%
Aortic Aneurysm Endovascular Graft
8%
Arm
5%
Bleeding Disorder
8%
Body Surface
8%
Cardiovascular Disease
5%
Coagulopathy
8%
Coughing
17%
Diagnosis
7%
Diarrhea
7%
Disease
24%
Drug Resistance
14%
Drug Sensitivity
24%
Emergency Department
8%
Encephalitis
5%
Health Care Cost
9%
Hemolytic Anemia
8%
HIV/AIDS
5%
Human Immunodeficiency Virus
60%
Human Immunodeficiency Virus Infection
7%
Immunocompromised Patient
6%
Infection
14%
Infection Control
17%
Influenza Vaccination
5%
Influenza Vaccine
8%
Influenza Virus
9%
Laboratory Test
9%
Latent Tuberculosis
14%
Lung Tuberculosis
17%
Lymphadenopathy
5%
Medical History
8%
Mixed Infection
7%
Multidrug Resistant Tuberculosis
25%
Mycobacterium Tuberculosis
15%
Placebo
5%
Public Health
6%
Real-Time Polymerase Chain Reaction
6%
Silo-Filler's Disease
5%
Sputum
12%
Tuberculosis
25%
Tuberculosis Treatment
7%